“Hydroxychloroquine Attenuates Myocardial Ischemic and Post-Ischemic Reperfusion Injury by Inhibiting the Toll-Like Receptor 9 – Type I Interferon Pathway”, ccm, vol. 6, no. 4, pp. 416–423, Aug. 2022, Accessed: Sep. 18, 2026. Available: https://fortunejournals.org/ojs/index.php/ccm/article/view/16285